BioVersys successfully advances BV500 NTM program with continued support from CF AMR syndicate
The company’s BV500 NTM program is derived from its proprietary Ansamycin Chemistry platform from which the research team has identified…
BEAM at work
Our advocacy work is based on analysis and reflection with our members.
Each topic is dealt with by a task force, which acts as a discussion platform and issues policy briefs.
